Target Biotech ApS: Financial statements 2022
CVR: 39676478
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Target Biotech ApS (CVR 39676478) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 402,821 and a net result of DKK 56,725 compared with DKK 87,717 the year before. That is a decrease of 17.3% compared with the year before. Equity in the 2022 report amounted to DKK 328,866. The solvency ratio was 92.7%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 402,821
- Profit/Loss
- DKK 56,725
- Equity
- DKK 328,866
- Total Assets
- DKK 354,811
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 403 t. | 57 t. | 329 t. | 1 |
| 2021 | - | 487 t. | 88 t. | 272 t. | 1 |
| 2020 | - | 365 t. | 24 t. | 184 t. | 1 |
| 2019 | - | 221 t. | 57 t. | 160 t. | 1 |
Official annual report
Keep an eye on Target Biotech ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Target Biotech ApS has published its annual report for 2021. Gross profit came to DKK 487,080, and the net result was DKK 87,717.
About Target Biotech ApS
Target Biotech ApS is a Danish company of the type Anpartsselskab based in Allerød, founded in 2018. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The management consists of Peter Horn Møller. The company is owned by Peter Horn Møller. The company has 0 employees (2018). In 2025, the company reported a gross profit of DKK -19,344 and a net result of DKK -7,028,421 compared with DKK 23,952,623 the year before. Equity in the 2025 report amounted to DKK 10,735,912.